adherence to therapy. Screening, evaluating, and treating this disorder is crucial and should be pursued systematically. 2 The diagnosis of a major depressive disorder in HIV-infected patients can be complicated. Both depression and HIV disease result in similar somatic or physical symptoms. Fatigue, lethargy, low libido, diminished appetite, and weight loss may be manifestations of either HIV-related illnesses or depressive disorder. In contrast, cognitive and affective symptoms such as feeling sad, lack of interest in formerly enjoyable activities, guilt, and irritability are usually components of mood alone.
In today's psychiatric clinical practice, rating scales have come to play an ever-increasing role both in determining specific symptoms and diagnosing individual condition. Descriptive reports of psychiatric morbidity among those with HIV infection, which relied primarily on self-report rating scales, described high rates of symptomatic depression. The Beck Depression Inventory (BDI) 3 is a 21-item self-rating scale for depression. A score ≥ 10 is indicative of the presence of significant depression. According to Svanborg and Aberg 4 the BDI is the most often used self-rating instrument for depressive symptoms and when compared with a self-rating version of the Montgomery Asberg Depression Rating Scale (MADRS-S), was found to be equivalent. Similar findings were found by Kalichman et al. 5 and Cockram et al. 6 when comparing with other rating scales.
In a study to determine the association of depressive symptoms with HIV-related mortality and decline in CD4 lymphocyte counts, Ickovis et al. 7 concluded that depressive symptoms are associated with HIV disease progression. In contrast, Evans
HIV in South Africa -depression and CD4 count
Objective. Published studies on the prevalence of depressive symptoms using rating scales and the relationship between depression and immune status offer inconsistent results. Depressive symptoms are common and impact on functioning, quality of life, and health status, highlighting the importance of diagnosis and treatment of patients with HIV infection. The aim of the study was to determine the occurrence of depression among HIV-positive patients using the Beck's Depression Inventory (BDI) and to determine a relationship, if any, between depressive symptoms and CD4 count.
Method. Forty-one patients aged 18 years or more were recruited from the HIV outpatient clinic. All the subjects completed the 21-item BDI and their CD4 counts were determined. Patients who had a score of 10 or more on the BDI were considered positive for a depressive disorder.
Results. More than half (56%) of the study sample had a BDI of ≥ 10 indicating significant symptoms of depression. There was no significant difference in the CD4 counts between the depressed and non-depressed groups (p > 0.05), and no correlation between CD4 counts and BDI scores in the total study sample (r = 0.27, p > 0.05). The affective components of the BDI contributed significantly to the overall BDI score compared with the somatic component (p < 0.05).
Conclusion. The evidence from the study supports the BDI as a suitable measure for identifying those patients who meet the Diagnostic and Statistical Manual of Mental Disorders (DSM) criteria for minor or major depression. The HIV epidemic is the most serious health challenge in South Africa and it is imperative that HIV-infected patients who complain of fatigue or insomnia be screened routinely for major depression, followed by a structured interview to confirm the diagnosis.
et al. 8 report that while levels of self-reported depressive symptoms in HIV-infected patients were high, no relationship was found between CD4 count and depressive symptoms, whereas viral load was positively correlated with elevated depressive symptoms. Greater distress was not associated with greater immunosuppression or more advanced illness stage, either concurrently or over time. Other studies also support this conclusion. [9] [10] [11] Published studies on the prevalence of depressive symptoms using rating scales and the relationship between depression and immune status offer inconsistent results. Depressive symptoms are common and impact on functioning, quality of life, and health status, highlighting the importance of diagnosis and treatment of patients with HIV infection.
Objectives
The aim of the study was to determine: (i) occurrence of depression among HIV-positive patients attending an outpatient treatment clinic, using the BDI; and (ii) the association, if any, between depressive symptoms and CD4 counts.
Method
Patients aged 18 years or more were recruited from the HIV outpatient clinic. All subjects gave written informed consent to participate in the study, which was approved by the Committee for
Research On Human Subjects, University of the Witwatersrand.
All the subjects completed the BDI self-rating scale and had their CD4 counts determined.
Measures

Beck's Depression Inventory
The BDI 3 is a self-administered 21-item self-report scale measur- describing increasing severity of the abnormality concerned.
The scores for the 21 questions are added to obtain a total.
Interpretation of the results is as follows: a score of 5 -9 indicates normal ups and downs, 10 -18 mild to moderate depression; 19 -29 moderate to severe depression and 30 -63 severe depression. 12 
Results
The study sample comprised of 41 patients. They were divided into two groups -those with a BDI score of < 10 and those with a score of ≥ 10 (Table I) .
More than half (N = 23, 56%) of the patients had a BDI of ≥10, There was no significant difference in the CD4 counts between the depressed and non-depressed groups (p = 0.22).
The majority of the patients were unmarried women, under 46 years of age with a grade 9 or higher level of education.
However there was no significant difference with regard to age, gender, marital status, employment status and highest level of education between the depressed and non-depressed groups (p > 0.05).
There was no correlation between the BDI scores and CD4
counts of the total study sample (r = 0.274, p > 0.05) (Fig. 1) .
The BDI looks at symptoms such as fatiguability, loss of appetite, weight loss, sleep disturbance and low energy level. These somatic symptoms may be attributable to HIV infection and to the progress of the disease and may confound the diagnosis.
The depressed patients' scores were further broken down to determine the contribution of this somatic component to their total scores (Table II) .
The majority of patients scored highly on the affective component compared with these five somatic components (p > 0.05) ( Fig. 2) .
articles 
Conclusion
Although our study leaves unanswered certain questions concerning screening for depression in patients with HIV, we can conclude that the evidence supports the reliability of the BDI as a screening tool. The HIV epidemic is the most serious health challenge in South Africa and it is imperative that HIV-infected patients who complain of fatigue or insomnia be screened routinely for major depression, followed by a structured interview to confirm the diagnosis and to treat the depression. 
